Literature DB >> 26202447

Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.

Kun Liu1, Baocun Sun1, Xiulan Zhao1, Xudong Wang2, Yanlei Li1, Zhiqiang Qiu2, Tieju Liu1, Qiang Gu1, Xueyi Dong1, Yanhui Zhang2, Yong Wang1, Nan Zhao1.   

Abstract

Aggressive tumor cells can mimic embryonic vasculogenic networks and form vasculogenic mimicry (VM). Preliminary studies demonstrated that hypoxia can promote VM formation; however, the underlying mechanism remains unclear. The present study aimed to investigate the role of the Twist1Bmi1 connection in hypoxia‑induced VM formation and the underlying mechanism. In the in vitro experiments, western blot analysis demonstrated that hypoxia upregulated the expression of Twist1, Bmi1, epithelial‑mesenchymal transition (EMT) markers, stem cell markers and VM‑associated markers. The 3D culture assay showed that hypoxia promoted VM formation in hepatocellular carcinoma (HCC) cell lines. Using transfection and in vitro cell experiments, the Twist1Bmi1 connection was confirmed to have an important role in inducing EMT, cell stemness and VM formation. In the in vivo experiments, the murine hypoxia models were established via incomplete femoral artery ligation and the mechanism by which hypoxia promoted Twist1 and Bmi1 expression and led to VM formation was demonstrated by immunohistochemistry staining and endomucin/periodic acid Schiff double‑staining. In conclusion, hypoxia upregulate the expression of Twist1 and Bmi1, and these two proteins have an important role in inducing EMT and cancer cell stemness, which contributed to VM formation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202447     DOI: 10.3892/ijmm.2015.2293

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  15 in total

1.  TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy.

Authors:  Satoshi Matsusaka; Wu Zhang; Shu Cao; Diana L Hanna; Yu Sunakawa; Ana Sebio; Masashi Ueno; Dongyun Yang; Yan Ning; Anish Parekh; Satoshi Okazaki; Martin D Berger; Wataru Ichikawa; Nobuyuki Mizunuma; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2016-03-16       Impact factor: 6.261

2.  Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinoma.

Authors:  Changwen Bo; Na Li; Xiuli Li; Xianwei Liang; Yonghui An
Journal:  Hum Cell       Date:  2016-05-06       Impact factor: 4.174

Review 3.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

Review 4.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

Review 5.  Hypoxic/Ischemic Inflammation, MicroRNAs and δ-Opioid Receptors: Hypoxia/Ischemia-Sensitive Versus-Insensitive Organs.

Authors:  Yimeng Chen; Yichen He; Shuchen Zhao; Xiaozhou He; Dong Xue; Ying Xia
Journal:  Front Aging Neurosci       Date:  2022-05-09       Impact factor: 5.702

6.  Expression of STAT3 and vasculogenic mimicry in gallbladder carcinoma promotes invasion and metastasis.

Authors:  Hongbing Zhou; Yin Yuan; Haixin Qian
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

Review 7.  TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.

Authors:  Hong Ren; Peizhun Du; Zongyu Ge; Yiting Jin; Di Ding; Xiuping Liu; Qiang Zou
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

8.  cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.

Authors:  Jiao Tang; Jianguo Wang; Lin Fan; Xiaoxuan Li; Na Liu; Wanxian Luo; Jihui Wang; Yifeng Wang; Ying Wang
Journal:  Oncotarget       Date:  2016-04-26

Review 9.  Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.

Authors:  Aparna Jayachandran; Bijay Dhungel; Jason C Steel
Journal:  J Hematol Oncol       Date:  2016-08-30       Impact factor: 17.388

Review 10.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.